Showing results (221-230 of 238) with videos related to
Sort By:
Pageof 24
Surgery|May 1, 1980
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary reportC A Hubay, O H Pearson, J S Marshall, et al.Iscience|February 21, 2025
P-cadherin-dependent adhesions are required for single lumen formation and HGF-mediated cell protrusions during epithelial morphogenesisSydnie K Tran, Jessanne Y Lichtenberg, Corinne E Leonard, et al.Carbon Balance and Management|December 3, 2016
Attribution of net carbon change by disturbance type across forest lands of the conterminous United StatesN L Harris, S C Hagen, S S Saatchi, et al.Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.Proceedings of the National Academy of Sciences of the United States of America|November 8, 2024
Microbial metabolism disrupts cytokine activity to impact host immune responseEleanor K P Marshall, Catarina Nunes, Sophie Burbaud, et al.Journal of the National Cancer Institute|June 17, 2004
Effect of calcium supplementation on the risk of large bowel polypsKristin Wallace, John A Baron, Bernard F Cole, et al.Cell Death and Differentiation|March 4, 2014
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivoT J Phesse, K B Myant, A M Cole, et al.Leukemia|February 10, 2016
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancersD P Granados, A Rodenbrock, J-P Laverdure, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 9, 2017
Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and AtherosclerosisAimee E Vozenilek, Aaron R Navratil, Jonette M Green, et al.Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.Pageof 24